The latest issue of Liver Internatioal (IF:4. 4), the official journal of the International Society of Hepatology, published online the content of a study on surgical resection of intrahepatic cholangiocarcinoma by Dr. Tao Li, deputy director of Qilu Hospital, Shandong University. The paper retrospectively analyzed the clinical case data of 283 patients with surgically resected intrahepatic cholangiocarcinoma and analyzed the prognosis of each stage of cholangiocarcinoma after surgery according to the latest international TNM tumor stage. This clinical study found that radical resection was the only treatment with the potential to cure intrahepatic cholangiocarcinoma. Tumor number, lymph node metastasis, vascular invasion and GGT level were independent predictors of prognosis after radical resection for intrahepatic cholangiocarcinoma. Interventional treatment does not improve survival after radical resection of early-stage intrahepatic cholangiocarcinoma. Interventional treatment after radical resection of advanced intrahepatic cholangiocarcinoma can significantly improve the prognosis of patients. Therefore, for early-stage intrahepatic cholangiocarcinoma, intervention is not recommended after radical resection, while intervention is recommended for advanced intrahepatic cholangiocarcinoma to improve the outcome.